Form 4: Tandem Diabetes Care Executive Vosseller Reports Stock Transactions

Leigh Vosseller, EVP & CFO of Tandem Diabetes Care, reports acquisition and disposal of company stock and restricted stock units (RSUs) on May 15, 2024.

Summary

• Leigh Vosseller, the EVP & CFO of Tandem Diabetes Care, filed a Form 4 detailing changes in beneficial ownership of the company's stock.
• On May 15, 2024, Vosseller acquired 1,358 shares of common stock through the Employee Stock Purchase Plan (ESPP) at a price of $15.64 per share.
• Vosseller also acquired shares through the vesting of Restricted Stock Units (RSUs).
• A total of 6,648 shares were acquired through RSU conversions at a price of $0.
• Shares were withheld by Tandem Diabetes Care to satisfy tax withholding requirements on the vesting of RSUs.
• Vosseller disposed of 2,374 shares to cover these tax obligations at a price of $47.37.
• Following these transactions, Vosseller directly owns 18,572 shares of common stock and indirectly owns 11,860 shares through a trust.
• Vosseller also holds derivative securities in the form of RSUs, with varying vesting schedules.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Positives

• The acquisition of shares through the ESPP demonstrates Vosseller's investment in the company's future.
• The vesting of RSUs is part of Vosseller's compensation package and aligns her interests with those of the shareholders.

Negatives

• The disposal of shares to cover tax obligations reduces Vosseller's direct holdings in the company.

Industry Context

Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions. These filings are common across publicly traded companies and are used to monitor insider activity.

Comparison to Industry Standards

• Executive compensation packages including RSUs are standard practice in the industry.
• Vesting schedules and tax withholding practices are also typical.
• Comparing Vosseller's holdings and transactions to those of executives at similar companies like Insulet (PODD) or Dexcom (DXCM) would provide further context.

Stakeholder Impact

• The filing provides transparency to shareholders regarding executive stock ownership.
• The transactions have a minimal direct impact on employees, customers, suppliers, or creditors.

Key Dates